BR0313732A - Compostos de pirimido tendo atividade antiproliferativa - Google Patents
Compostos de pirimido tendo atividade antiproliferativaInfo
- Publication number
- BR0313732A BR0313732A BR0313732-5A BR0313732A BR0313732A BR 0313732 A BR0313732 A BR 0313732A BR 0313732 A BR0313732 A BR 0313732A BR 0313732 A BR0313732 A BR 0313732A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- pyrimide
- antiproliferative activity
- selective
- fgfr
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000001028 anti-proliverative effect Effects 0.000 title abstract 3
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 108091008794 FGF receptors Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 208000029742 colonic neoplasm Diseases 0.000 abstract 1
- 102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 208000037841 lung tumor Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000575 pesticide Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000023958 prostate neoplasm Diseases 0.000 abstract 1
- 150000003230 pyrimidines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"COMPOSTOS DE PIRIMIDO TENDO ATIVIDADE ANTIPROLIFERATIVA". A presente invenção refere-se a compostos de pirimido da fórmula I que são inibidores seletivos de ambas cinases de FGFR e KDR e são seletivos contra LCK. Esses compostos e seus sais farmaceuticamente aceitáveis são agentes antiproliferativos úteis no tratamento ou controle de tumores sólidos, em tumores de mama, cólon, pulmão e próstata particulares. São também descritas composições farmacêuticas contendo esses compostos e um processo para sua preparação.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40351902P | 2002-08-14 | 2002-08-14 | |
PCT/EP2003/008744 WO2004018472A2 (en) | 2002-08-14 | 2003-08-07 | Pyrimido compounds having antiproliferative activity |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0313732A true BR0313732A (pt) | 2005-09-27 |
Family
ID=31946709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0313732-5A BR0313732A (pt) | 2002-08-14 | 2003-08-07 | Compostos de pirimido tendo atividade antiproliferativa |
Country Status (19)
Country | Link |
---|---|
US (1) | US7084270B2 (pt) |
EP (1) | EP1556384B1 (pt) |
JP (1) | JP2005538141A (pt) |
KR (1) | KR20070087687A (pt) |
CN (1) | CN1323080C (pt) |
AR (1) | AR040971A1 (pt) |
AT (1) | ATE386743T1 (pt) |
AU (1) | AU2003255389A1 (pt) |
BR (1) | BR0313732A (pt) |
CA (1) | CA2494127A1 (pt) |
DE (1) | DE60319255T2 (pt) |
ES (1) | ES2300644T3 (pt) |
MX (1) | MXPA05001629A (pt) |
PA (1) | PA8580001A1 (pt) |
PL (1) | PL375588A1 (pt) |
RU (1) | RU2336275C2 (pt) |
TW (1) | TW200407326A (pt) |
UY (1) | UY27937A1 (pt) |
WO (1) | WO2004018472A2 (pt) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007002096A (es) | 2004-08-31 | 2007-03-29 | Hoffmann La Roche | Derivados de amida de 3-fenil-dihidropirimido[4,5-d] pirimidinonas, su fabricacion y su uso como agentes farmaceuticos. |
US7494993B2 (en) | 2004-08-31 | 2009-02-24 | Hoffmann-La Roche Inc. | Amide derivatives of 7-amino-3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
JP2012518657A (ja) | 2009-02-25 | 2012-08-16 | オーエスアイ・ファーマシューティカルズ,エルエルシー | 併用抗癌治療 |
JP2012519282A (ja) | 2009-02-27 | 2012-08-23 | オーエスアイ・ファーマシューティカルズ,エルエルシー | 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法 |
WO2010099138A2 (en) | 2009-02-27 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
JP2012519281A (ja) | 2009-02-27 | 2012-08-23 | オーエスアイ・ファーマシューティカルズ,エルエルシー | 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法 |
US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
EP2702173A1 (en) | 2011-04-25 | 2014-03-05 | OSI Pharmaceuticals, LLC | Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment |
CN102816162B (zh) * | 2011-06-10 | 2016-04-27 | 中国科学院广州生物医药与健康研究院 | 嘧啶并嘧啶酮类化合物及其药用组合物和应用 |
WO2013152252A1 (en) | 2012-04-06 | 2013-10-10 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
DK2861595T5 (en) | 2012-06-13 | 2018-01-15 | Incyte Holdings Corp | Substituted tricyclic compounds as FGFR inhibitors |
WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
CN104968664A (zh) * | 2012-12-12 | 2015-10-07 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的并环化合物 |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
CA2907243C (en) | 2013-03-15 | 2021-12-28 | Celgene Avilomics Research, Inc. | Substituted dihydropyrimidopyrimidinone compounds and pharmaceutical compositions thereof use fgfr4 inhibitor |
AR095464A1 (es) | 2013-03-15 | 2015-10-21 | Celgene Avilomics Res Inc | Compuestos de heteroarilo y usos de los mismos |
MX2015011514A (es) | 2013-03-15 | 2016-08-11 | Celgene Avilomics Res Inc | Compuestos de heteroarilo y sus usos. |
MX367878B (es) | 2013-04-19 | 2019-09-10 | Incyte Holdings Corp | Heterociclos bicíclicos como inhibidores de los receptores del factor de crecimiento de fibroblastos (fgfr). |
CN104418860B (zh) * | 2013-08-20 | 2016-09-07 | 中国科学院广州生物医药与健康研究院 | 嘧啶并杂环类化合物及其药用组合物和应用 |
CA2954187C (en) | 2014-07-21 | 2022-08-16 | Dana-Farber Cancer Institute, Inc. | Macrocyclic kinase inhibitors and uses thereof |
AU2015292818B2 (en) | 2014-07-21 | 2020-01-16 | Dana-Farber Cancer Institute, Inc. | Imidazolyl kinase inhibitors and uses thereof |
EP3536323A1 (en) | 2014-08-08 | 2019-09-11 | Dana Farber Cancer Institute, Inc. | Uses of salt-inducible kinase (sik) inhibitors |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
EP3259269B9 (en) | 2015-02-20 | 2020-03-04 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
CA3069016A1 (en) | 2016-07-05 | 2018-01-11 | The Broad Institute, Inc. | Bicyclic urea kinase inhibitors and uses thereof |
US11241435B2 (en) | 2016-09-16 | 2022-02-08 | The General Hospital Corporation | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis |
CA3054809A1 (en) * | 2017-02-28 | 2018-09-07 | The General Hospital Corporation | Uses of pyrimidopyrimidinones as sik inhibitors |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
JP2021523118A (ja) | 2018-05-04 | 2021-09-02 | インサイト・コーポレイションIncyte Corporation | Fgfr阻害剤の塩 |
BR112020022392A2 (pt) | 2018-05-04 | 2021-02-02 | Incyte Corporation | formas sólidas de um inibidor de fgfr e processos para preparação das mesmas |
WO2020139992A1 (en) * | 2018-12-27 | 2020-07-02 | Agios Pharmaceuticals, Inc. | Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer |
US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
BR112022007163A2 (pt) | 2019-10-14 | 2022-08-23 | Incyte Corp | Heterociclos bicíclicos como inibidores de fgfr |
WO2021076728A1 (en) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
JP2023505258A (ja) | 2019-12-04 | 2023-02-08 | インサイト・コーポレイション | Fgfr阻害剤としての三環式複素環 |
IL293001A (en) | 2019-12-04 | 2022-07-01 | Incyte Corp | Derivatives of fgfr repressors |
US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
EP4323405A1 (en) | 2021-04-12 | 2024-02-21 | Incyte Corporation | Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent |
JP2024522189A (ja) | 2021-06-09 | 2024-06-11 | インサイト・コーポレイション | Fgfr阻害剤としての三環式ヘテロ環 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2949466A (en) | 1958-03-04 | 1960-08-16 | Parke Davis & Co | Pyrimidine compounds and means of producing the same |
ES338687A1 (es) | 1966-04-06 | 1968-04-01 | Monsanto Co | Procedimiento para obtener composiciones de fluidos funcio-nales. |
US4425346A (en) | 1980-08-01 | 1984-01-10 | Smith And Nephew Associated Companies Limited | Pharmaceutical compositions |
JPS60226882A (ja) | 1984-04-24 | 1985-11-12 | Nippon Zoki Pharmaceut Co Ltd | 新規ピリミドピリミジン誘導体 |
AU7622698A (en) | 1996-12-05 | 1998-06-29 | Sugen, Inc. | Use of indolinone compounds as modulators of protein kinases |
EA003640B1 (ru) | 1998-05-26 | 2003-08-28 | Варнер-Ламберт Компани | Бициклические пиримидины и бициклические 3,4-дигидропиримидины как ингибиторы клеточной пролиферации |
ES2228123T3 (es) | 1998-10-23 | 2005-04-01 | F. Hoffmann-La Roche Ag | Heterociclos de nitrogeno biciclicos. |
EP1228070B1 (en) | 1999-10-21 | 2007-02-07 | F. Hoffmann-La Roche Ag | Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
KR100537241B1 (ko) | 1999-10-21 | 2005-12-19 | 에프. 호프만-라 로슈 아게 | P38 단백질 키나제의 억제제로서의 알킬아미노 치환된이중고리 질소 헤테로고리 화합물 |
AR030053A1 (es) | 2000-03-02 | 2003-08-13 | Smithkline Beecham Corp | 1h-pirimido [4,5-d] pirimidin-2-onas y sales, composiciones farmaceuticas, uso para la fabricacion de un medicamento y procedimiento para producirlas |
CN1275964C (zh) | 2000-08-31 | 2006-09-20 | 霍夫曼-拉罗奇有限公司 | 作为细胞增殖抑制剂的7-氧代吡啶并嘧啶 |
US7196090B2 (en) | 2002-07-25 | 2007-03-27 | Warner-Lambert Company | Kinase inhibitors |
-
2003
- 2003-07-21 US US10/623,972 patent/US7084270B2/en not_active Expired - Fee Related
- 2003-08-07 CN CNB038191601A patent/CN1323080C/zh not_active Expired - Fee Related
- 2003-08-07 KR KR1020077017079A patent/KR20070087687A/ko not_active Application Discontinuation
- 2003-08-07 MX MXPA05001629A patent/MXPA05001629A/es active IP Right Grant
- 2003-08-07 WO PCT/EP2003/008744 patent/WO2004018472A2/en active IP Right Grant
- 2003-08-07 BR BR0313732-5A patent/BR0313732A/pt not_active IP Right Cessation
- 2003-08-07 CA CA002494127A patent/CA2494127A1/en not_active Abandoned
- 2003-08-07 RU RU2005107314/04A patent/RU2336275C2/ru not_active IP Right Cessation
- 2003-08-07 DE DE60319255T patent/DE60319255T2/de not_active Expired - Fee Related
- 2003-08-07 AU AU2003255389A patent/AU2003255389A1/en not_active Abandoned
- 2003-08-07 PL PL03375588A patent/PL375588A1/xx not_active Application Discontinuation
- 2003-08-07 EP EP03792269A patent/EP1556384B1/en not_active Expired - Lifetime
- 2003-08-07 ES ES03792269T patent/ES2300644T3/es not_active Expired - Lifetime
- 2003-08-07 AT AT03792269T patent/ATE386743T1/de not_active IP Right Cessation
- 2003-08-07 JP JP2004530098A patent/JP2005538141A/ja active Pending
- 2003-08-11 PA PA20038580001A patent/PA8580001A1/es unknown
- 2003-08-12 UY UY27937A patent/UY27937A1/es not_active Application Discontinuation
- 2003-08-12 AR ARP030102914A patent/AR040971A1/es not_active Application Discontinuation
- 2003-08-13 TW TW092122274A patent/TW200407326A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ES2300644T3 (es) | 2008-06-16 |
TW200407326A (en) | 2004-05-16 |
AU2003255389A1 (en) | 2004-03-11 |
US20040038995A1 (en) | 2004-02-26 |
MXPA05001629A (es) | 2005-04-25 |
UY27937A1 (es) | 2004-02-27 |
DE60319255D1 (de) | 2008-04-03 |
PL375588A1 (en) | 2005-11-28 |
DE60319255T2 (de) | 2009-03-05 |
PA8580001A1 (es) | 2004-03-10 |
ATE386743T1 (de) | 2008-03-15 |
EP1556384B1 (en) | 2008-02-20 |
US7084270B2 (en) | 2006-08-01 |
CN1323080C (zh) | 2007-06-27 |
JP2005538141A (ja) | 2005-12-15 |
CA2494127A1 (en) | 2004-03-04 |
AR040971A1 (es) | 2005-04-27 |
KR20070087687A (ko) | 2007-08-28 |
WO2004018472A3 (en) | 2004-04-29 |
CN1675214A (zh) | 2005-09-28 |
RU2005107314A (ru) | 2005-11-20 |
EP1556384A2 (en) | 2005-07-27 |
RU2336275C2 (ru) | 2008-10-20 |
WO2004018472A2 (en) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0313732A (pt) | Compostos de pirimido tendo atividade antiproliferativa | |
BRPI0409366A (pt) | compostos de pirimido | |
BR0213242A (pt) | Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto | |
BR0315912A (pt) | Compostos pirimìdicos com atividade antiproliferativa (ii) | |
BR0214485A (pt) | 3-cianoquinolinas como inibidores de egf-r e her2 quinases | |
BR0215312A (pt) | Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto | |
TR200302242T2 (tr) | Protein kinaz önleyicileri olarak pirolopirimidinler | |
BR0206496A (pt) | Diaminotiazóis | |
BR0012590A (pt) | Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central | |
BR0205889A (pt) | Pirazolopirimidinas como agentes tepapêuticos | |
BRPI0413746A (pt) | composto ou um seu n-óxido ou seu sal farmaceuticamente aceitável, composição, e, método de tratamento de distúrbio hiperproliferativo | |
BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
BR0317572A (pt) | Benzoxazinas e seus derivados como inibidores de pi3ks | |
CO5271691A1 (es) | Nuevos compuestos | |
BR0113358A (pt) | Derivado de quinazolina ou de um seu sal farmaceuticamente aceitável, processo para a sua preparação, composição farmacêutica, e, uso do derivado ou de um seu sal farmaceuticamente aceitável | |
BRPI0417260A (pt) | derivados de azepinoindol como agentes farmacêuticos | |
BR0317480A (pt) | Derivados de piridino[2,3-d]pirimidina como inibidores kdr e fgfr seletivos | |
BR0109650A (pt) | 3-cianoquinolinas, 3-ciano-1,6-naftiridinas e 3-ciano-1,7-naftiridinas como inibidores da cinase proteìca | |
BR0308243A (pt) | Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero | |
NO20060971L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
NO20063572L (no) | Kinazolinditosylatsalt forbindelser | |
BRPI0413785A (pt) | composto, composição, e, método de tratamento de distúrbio hiperproliferativo | |
ATE408601T1 (de) | Fredericamycin-derivate | |
BRPI0413740A (pt) | composto ou um seu n-óxido ou seu sal farmaceuticamente aceitável, composição, e, método de tratamento de distúrbio hiperproliferativo | |
BR0210075A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: BASEADO NO ART. 216 1 DA LPI, APRESENTE COPIA AUTENTICADA DA PROCURACAO PARA QUE ESTA SEJA ACEITA. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |